8BFD78F6 F409 45EB A596 D2B13F9831E6          

 

劉博侖 教授                                                                                

聯絡電話:07-31211012801 

E-Mailkisa@kmu.edu.tw

office hour:每週二、四 15001700

職稱

教授

學歷/經歷

國立陽明大學生理學研究所博士

國立陽明大學解剖暨細胞生物研究所碩士

國立台北護理學院學士

專長領域         

解剖學

呼吸生理學

動脈硬化防治

細胞分子生理學

教學科目

生理學

解剖學

基礎心電圖

分子生物學

組織學概論

心肺解剖生理學

心肺血管疾病特論

呼吸治療研究導論

細胞生理學研究技術

五年著作目錄

1.        Chong-Chao Hsieh, Hsuan-Fu Kuo, Hsiao-Hsuan Wang, Mo Da-Sang Hua, I-Line Chen, Jia-Ling Lin, Yi-Ching Lo, Zi-Jing Lin, Yung-Hsiang Chen, Yur-Ren Kuo, Chih-Hsin Hsu, Po-Len Liu*. (2025 Sep). Plumbagin improves pulmonary vascular remodeling in PAH via miR-21-5p/MMP/TIMP regulation, with diagnostic implications for cardiac function. Biomed Pharmacother. 192:118604. (本人為通訊作者)

2.        Po-Len Liu, Zhi-Wei Xu, Wen-Shuo Kuo, Chih-Hsin Hsu, Yu-Ru Liu, Min-Zhen Lu, Sheng-Bo Lai, Jui-Chi Chang, Hsiao-Hsuan Wang, Chia-Yuan Chang. (2025 Jul). Pulmonary artery hypertension-induced vascular structure analysis using label-free fluorescence lifetime imaging. Opt Experss. 28;33(15):31935-31948.(本人為第一作者)

3.        Meng-HsuanChengHsiao-HsuanWangMoDa-SangHuaHsuan-FuKuoZi-JingLinChong-ChaoHsiehChih-HsinHsuChia-YangLiShu-ChiWangYung-HsiangChenSzu-HuiWuWei-LunLiu, Po-Len Liu*. (2025 Jun). Magnolol facilitates mitochondrial-peroxisome dysfunction and induces oxeiptosis in lung cancer cells following transfer via tunneling nanotubes. Biomed Pharmacother. 187:118126. (本人為通訊作者)

4.        Meng-Hsuan Cheng, Hsuan-Fu Kuo, Chia-Yuan Chang, Jui-Chi Chang, I-Fan Liu, Chong-Chao Hsieh, Chih-Hsin Hsu, Chia-Yang Li, Shu-Chi Wang, Yung-Hsiang Chen, Chuang-Rung Chang, Tsung-Ying Lee, Yu-Ru Liu, Chi-Yuan Huang, Szu-Hui Wu, Wei-Lun Liu, Po-Len Liu*. (2024 May). Curcumin regulates pulmonary extracellular matrix remodeling and mitochondrial function to attenuate pulmonary fibrosis by regulating the miR-29a-3p/DNMT3A axis. Biomed Pharmacother. 174:116572. (本人為通訊作者)

5.        Ting-En Chen, Jung Lo, Shu-Pin Huang, Kun-Che Chang, Po-Len Liu, Hsin-En Wu, Yuan-Ru Chen, Yo-Chen Chang, Ching-Chih Liu, Po-Yen Lee, Yu-Hung Lai, Pei-Chang Wu, Shu-Chi Wang, Chia-Yang Li*. (2024 Oct). Glaucine inhibits hypoxia-induced angiogenesis and attenuates LPS-induced inflammation in human retinal pigment epithelial ARPE-19 cells. Eur J Pharmacol. 2024 Oct 15:981:176883.

6.        Hsin-En Wu, Chia-Cheng Su, Shu-Chi Wang, Po-Len Liu, Wei-Chung Cheng, Hsin-Chih Yeh, Chih-Pin Chuu, Jen-Kun Chen, Bo-Ying Bao, Cheng Hsueh Lee, Chien-Chih Ke, Yuan-Ru Chen, Yun-Hsin Yu, Shu-Pin Huang, and Chia-Yang Li*. (2023 Apr). Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway. Am J Chin Med. 51(4):1019-1039.

7.        Yu-Hung Lai, Wei-Lun Liu, Tsung-Ying Lee, Chung-Wen Kuo, Yu-Ru Liu, Chi-Yuan Huang, Yung-Hsiang Chen, I-Ling Chen, Szu-Hui Wu, Shu-Chi Wangi, Po-Yen Lee, Ching-Chih Liu, Jung Lo, Yo-Chen Chang, Hsuan-Fu Kuo, Chong-Chao Hsieh, Chia-Yang Li, and Po-Len Liu*. (2023 Feb). Magnolol regulates miR-200c-3p to inhibit EMT and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo. Phytomedicine. 110:154597. (本人為通訊作者)

8.        Fan Liu, Tzu-Chieh Lin, Shu-Chi Wang, Chia-Hung Yen, Chia-Yang Li, Hsuan-Fu Kuo, Chong-Chao Hsieh, Chia-Yuan Chang, Chuang-Rung Chang, Yung-Hsiang Chen, Yu-Ru Liu, Tsung-Ying Lee, Chi-Yuan Huang, Chih-Hsin Hsu*, Shing-Jong Lin* and Po-Len Liu*. (2023 Mar). Long-term administration of Western diet induced metabolic syndrome in mice and causes cardiac microvascular dysfunction, cardiomyocyte mitochondrial damage, and cardiac remodeling involving caveolae and caveolin-1 expression. Biol Direct. 18(1):9. (本人為通訊作者)

9.        Yuan-Ru Chen, Shu-Chi Wang, Shu-Pin Huang, Chia-Cheng Su, Po-Len Liu, Wei-Chung Cheng, Chih-Pin Chuu, Jen-Kun Chen, Bo-Ying Bao, Cheng Hsueh Lee, Chien-Chih Ke, Hsin-En Wu, Hao-Han Chang, Hsin-Chih Yeh*, and Chia-Yang Li*. (2022 Dec). Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways. Biomed Pharmacother. 156:113929.

10.   Jung Lo, Ching-Chih Liu, Yueh-Shan Li, Po-Yen Lee, Po-Len Liu, Pei-Chang Wu, Tzu-Chieh Lin, Chi-Shuo Chen, Chien-Chih Chiu, Yu-Hung Lai, Yo-Chen Chang, Hsin-En Wu, Yuan-Ru Chen, Yu-Kai Huang, Shu-Pin Huang, Shu-Chi Wang, and Chia-Yang Li*. (2022 Sep). Punicalagin Attenuates LPS-Induced Inflammation and ROS Production in Microglia by Inhibiting the MAPK/NF-κB Signaling Pathway and NLRP3 Inflammasome Activation. J Inflamm Res. 15:5347-5359.

11.   Szu-Ju Chen, Sunderiya Dalanbaatar, Huey-Yi Chen, Shih-Jing Wang, Wei-Yong Lin, Po-Len Liu, Ming-Yen Tsai, Der-Cherng Chen, Yung-Hsiang Chen, and Wen-Chi Chen. (2022 Aug). Astragalus membranaceus Extract Prevents Calcium Oxalate Crystallization and Extends Lifespan in a Drosophila Urolithiasis Model. Life (Basel). 12(8):1250.

12.   Hsin-Chih Yeh, Chia-Cheng Su, Yen-Hsuan Wu, Cheng Hsueh Lee, Bo-Ying Bao, Wei-Chung Cheng, Shu-Chi Wang, Po-Len Liu, Chien-Chih Chiu, Chih-Pin Chuu , Chien-Chih Ke, Hsin-En Wu, Yuan-Ru Chen, Wei-Ju Chung, Shu-Pin Huang, and Chia-Yang Li*. (2022 May). Novel insights into the anti-cancer effects of 3-bromopyruvic acid against castration-resistant prostate cancer. Eur J Pharmacol. 923:174929.

13.   Chen Chen, Shu-Chi Wang, Yi-Ting Chen, Hsin-Han Tseng, Po-Len Liu, Tzu-Chieh Lin, Hsin-En Wu, Yuan-Ru Chen, Yu-Hsin Tseng, Jong-Hau Hsu, Zen-Kong Dai, Jau-Ling Suen, and Chia-Yang Li*. (2021 Oct). Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6/STAT3 Signaling Pathways. Pharmaceuticals (Basel). 14(10):1046.

14.   Hsuan-Fu Kuo, I-Fan Liu, Chia-Yang Li, Chien-Sung Tsai, Yung-Hsiang Chen, Wei-Shiung Lian, Tzu-Chieh Lin, Yu-Ru Liu, Tsung-Ying Lee, Chi-Yuan Huang, Chong-Chao Hsieh, Chih-Hsin Hsu, Feng-Yen Lin, and Po-Len Liu*. (2021, Oct). Endocardial Endothelial Dysfunction and Unknown Polymorphic Composite Accumulation in Heart Failure. Biomedicines. 9(10):1465. (本人為通訊作者)

15.   Chih-Hsin Hsu, I-Fan Liu, Hsuan-Fu Kuo, Chia-Yang Li, Wei-Shiung Lian, ChiaYuan Chang, Yung-Hsiang Chen, Wei-Lun Liu, Chi-Yu Lu , Yu-Ru Liu, Tzu-Chieh Lin, Tsung-Ying Lee, Chi-Yuan Huang, Chong-Chao Hsieh*, and Po-Len Liu*. (2021, Sep). miR-29a-3p/ HBS2 Axis Regulates PAH-induced Cardiac Fibrosis. International Journal of Molecular Sciences. 22(19), 10574. (本人為通訊作者)

16.   Wei-Lun Liu, Chia-Yang Li, Wei-Chung Cheng, Chia-Yuan Chang, Yung-Hsiang Chen, Chi-Yu Lu, Shu-Chi Wang, Yu-Ru Liu, Meng-Hsuan Cheng, Inn-Wen Chong, and Po-Len Liu*. (2021, Mar). High Mobility Group Box 1 Promotes Lung Cancer Cell Migration and Motility via Regulation of Dynamin-Related Protein 1. Int J Mol Sci. 22(7):3628. (本人為通訊作者)

17.   Yu-Hung Lai, Po-Yen Lee, Chi-Yu Lu, Yu-Ru Liu, Shu-Chi Wang, Ching-Chih Liu, Yo-Chen Chang, Yung-Hsiang Chen, Chia-Cheng Su, Chia-Yang Li, and Po-Len Liu*. (2020, Jan). Thrombospondin 1-induced exosomal proteins attenuate hypoxia-induced paraptosis in corneal epithelial cells and promote wound healing. FASEB J. 35(1):e21200. (本人為通訊作者)

18.   Yung-Hsiang Chen, Wen-Chi Chen, Kao-Sung Tsai, Po-Len Liu, Ming-Yen Tsai, Shih-Chieh Yu, and Huey-Yi Chen. (2020, Jul). Efficacy of Frankincense and Myrrha in Treatment of Acute Interstitial Cystitis/Painful Bladder Syndrome. Chin J Integr Med. 26 (7):519-526.

19.   Yung-Hsiang Chen, Wen-Chi Chen, Po-Len Liu, and Huey-Yi Chen*. (2020, Mar). Astragalus polysaccharides and astragaloside IV ameliorates cyclophosphamideinduced mouse model of overactive bladder. Taiwan J Obstet Gynecol. 59(2):248-255.

20.   Chong-Chao Hsieh, Chia-Yang Li, Chih-Hsin Hsu, Hsiu-Lin Chen, Yung-Hsiang Chen, Yu-Peng Liu, Yu-Ru Liu, Hsuan-Fu Kuo*, and Po-Len Liu*. (2019, Oct). Mitochondrial protection by simvastatin against angiotensin II-mediated heart failure. British Journal of Pharmacology.176(19):3791-3804. MOST 104-2314-B-037-087. (本人為通訊作者)

21.   Hsuan-Fu Kuo, Chong-Chao Hsieh, Shu-Chi Wang, Chia-Yuan Chang, Chih-Hsin Hung, Po-Lin Kuo, Yu-Ru Liu, Chia-Yang, Po-Len Liu*. (2019, Jun). Simvastatin Attenuates Cardiac Fibrosis via Regulation of Cardiomyocyte- Derived Exosome Secretion. J Clin Med. 8(6):794. MOST 104-2314-B-037-087. (本人為通訊作者)

22.   Rong-Hsing Chen, Kee-Ming Man, Huey-Yi Chen, Szu-Ju Chen, Wei-Shan Chen, Po-Len Liu, Yung-Hsiang Chen,* and Wen-Chi Chen*. (2019, May). Thyroid Diseases Increased the Risk of Type 2 Diabetes Mellitus: A Nation-wide Cohort Study. Medicine (Baltimore). 98(20): e15631. 

23.   Wen-Tsung Huang, Inn-Wen Chong, Hsiu-Lin Chen, Chia-Yang Li, Chong-Chao Hsieh, Hsuan-Fu Kuo, Chia-Yuan Chang, Yung-Hsiang Chen, Yu-Peng Liu, Chi-Yu Lu, Yu-Ru Liu, Po-Len Liu*. (2019, Feb). Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1. Cancer Lett. 442:287-298. MOST 104-2314-B-037-087. (本人為通訊作者).

近三年研究計畫

計畫名稱

(本部補助者請註明編號)

計畫內擔任之工作

起迄年月

補助或

委託機構

執行

情形

經費總額

透過COVID-19病人之miRNA定序,篩選抗纖維化之miRNA及新藥開發

MOST 111-2320-B-037-036

共同

主持人

2022/08/01~

2023/07/31

國科會

已結案

1,200,000

開發具粒線體靶定之厚朴酚藥物及評估其對非小細胞肺癌的臨床治療潛力MOST111-2314-B-037-114 (校內編號:N111237)

共同

主持人

2022/08/01~

2023/08/01

國科會

已結案

910,000

解析和厚朴抗纖維化機制及評估其對成人呼吸窘迫症候群後肺纖維化的臨床治療潛力

MOST111-2314-B-030-008 

共同

主持人

2022/08/01~ 2023/08/01

國科會

已結案

920,000

探討薑黃素調控miR-29a-3p的抗肺纖維化作用及其機制 MOST110-2314-B-037-125

(校內編號:N110224) 

共同

主持人

2021/08/01~

2022/07/31

國科會

已結案

1,120,000

探索鳶尾素對減輕肺動脈高壓進展的調節機制MOST109-2314-B-006-094-MY3

共同

主持人

2020/08/01~

2023/07/31

國科會

已結案

4,592,000

探討厚朴酚與厚朴酚具粒線體標靶衍生物抑制博來黴素誘導肺纖維化的表關遺傳調控與逆轉肺纖維化的功效 (校內編號:N112127)

NSTC 112-2320-B-037-024 

主持人

2023/08/01~ 2024/08/01

國科會

已結案

1,100,000

探討厚朴酚衍生物透過調節表觀遺傳和粒線體功能來抑制野百合鹼所誘導的肺動脈高壓NSTC112-2314-B-006-056-MY3

共同

主持人

2023/08/01~

2026/07/31

國科會

執行中

4,560,000

探討代謝症候群所導致小鼠心臟微血管功能障礙、小窩和小窩蛋白-1表達、心肌線粒體損傷與心臟重塑

KMU-DK(A) 112003

主持人

2023/01/01~ 2023/12/31

高雄醫學大學

已結案

820,000

探討粒線體透過隧道奈米管運輸在抗腫瘤治療上的潛力與運用

KMU-DK(A)113010

主持人

2024/01/01~ 2024/12/31

高雄醫學大學

已結案

820,000

探討miR-19a-3p/POSTN軸調節ARDS衍生之肺纖維化於臨床治療上的潛力與運用

KMU-DK(A)114002

主持人

2025/01/01~ 2025/12/31

高雄醫學大學

執行中

820,000

探討厚朴酚在視網膜母細胞瘤中的抗癌作用及其作用機制

KMUH110-0M48

共同主持人

2022/01/01~

2022/12/31

高醫附院計畫

(指導型)

已結案

330,000

開發具粒腺體靶定之厚朴酚藥物及評估其對非小細胞肺癌的臨床治療潛力

KMUH111-1R10

共同主持人

2023/01/01~

2023/12/31

高醫附院計畫

(獎勵型)

已結案

200,000

探討厚朴酚透過調控miR-505-3p的表達對於視網膜母細胞癌的抗腫瘤功效

KMUH112-2M37

共同主持人

2023/01/01~

2023/12/31

高醫附院計畫

(指導型)

已結案

220,000

探討粒線體透過遷移體與隧道奈米管運輸與在抗腫瘤治療上的潛力與運用

KMUH113-3R12

共同主持人

2025/01/01~

2025/12/31

高醫附院計畫

(獎勵型)

已結案

220,000

探討Atorvastatin透過調控反向心臟重塑抑制心衰竭的進展

KMGH-113G003

共同主持人

2025/01/01~

2025/12/31

高醫岡山醫院計畫

(指導型)

執行中

253,000

專利

1.      美國: DR20A NOVEL ANTI-FIBROTIC, ANTI-CANCER, ANTI-PAH THERAPIES DRUG(63/716, 785),劉博侖、林韋佑、郭炫孚、鄭孟軒

2.      美國: 用於促進皮膚細胞增生及/或遷移的組成物、生薑萃取物及其醫藥組成物(8,772,347),王惠民、陳中一、邱建志、周怡廷、劉博侖

3.      中華民國: 具雙影像追蹤探針之高分子奈米載體及其製備方法(I530296),王志光、潘力誠、李之昀、林宏哲、林哲緯、劉博侖、史秉修

4.      中華民國: 用於促進皮膚細胞增生及/或遷移的組成物,生薑促取物及醫藥組成物(I446919),王惠民、陳中一、邱建志、周怡廷、劉博侖

Go to top